Malaria Vaccines Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Malaria Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for malaria vaccines has experienced substantial expansion in the past few years. It is predicted to escalate from $4.7 billion in 2024 to around $6.3 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 34.0%. This remarkable growth during the historic period is directly proportional to the high burden of malaria, international health initiatives, financial aid, malaria control schemes, governmental assistance, and relevant regulatory frameworks.

Malaria Vaccines Market Size Forecast: What's the Projected Valuation by 2029?
The market for malaria vaccines is projected to experience a surge in size in the coming years. By 2029, it is predicted to expand to $20.65 billion, with a Compound Annual Growth Rate (CAGR) of 34.5%. The expected growth during the forecast period is linked to global eradication objectives, extended access plans, heightened vaccine coverage, international vaccine collaborations, and the effects of climate change. During the forecast period, key trends include technological breakthroughs, collaborations between public and private sectors, global cooperation, and advancements in the field of vaccine technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

What Are the Drivers Transforming the Malaria Vaccines Market?
The increase in mosquito-borne diseases is anticipated to boost the malaria vaccine market's expansion. These diseases, passed on via the bite of an infected mosquito, span a wide range. The RTS, S/AS01 (RTS, S) malaria vaccine particularly helps to mitigate the effects of these mosquito-transmitted diseases by priming the immune system to detect and fight the parasite. The World Health Organization, a Switzerland-based intergovernmental body, provided an instance in a November 2023 report. It estimated that the global occurrence of malaria in 2022 was 249 million cases, a rise of 5 million from the previous year. Moreover, Pakistan saw an estimated 2.6 million cases in 2022, a significant surge from just 500,000 in 2021. Consequently, the escalating incidence of mosquito-borne diseases is spurring the malaria vaccine market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

What Long-Term Trends Will Define the Future of the Malaria Vaccines Market?
Key players in the malaria vaccine market, like the major corporations, are diversifying their product portfolios, incorporating novel products such as vaccines against malaria in children. This is in a bid to seize more customers, boost sales, and subsequently enhance their revenue. Vaccines for mosquito-transmitted diseases are immune formulations purposed to offer protection against mosquito-transmitted illnesses. The malaria vaccine focuses on Plasmodium falciparum, which is globally the deadliest malaria parasite and holds the highest prevalence in Africa. In November 2022, for example, the World Health Organization, based in Switzerland, partnered with Malawi, an East African nation, to roll out the first children's malaria vaccine in Africa. The RTSS vaccine, specifically designed for the young population, stands out due to its potential to lessen fatalities from the mosquito-transmitted disease. Despite an effectiveness rate of roughly 30%, there has been testing on over one million children in Ghana, Kenya, and Malawi, sparking hope that the vaccine could aid in saving some lives among the 400,000 people who die from malaria yearly.

Which Segments in the Malaria Vaccines Market Offer the Most Profit Potential?
The malaria vaccines market covered in this report is segmented -

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines
3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes
4) By Distribution Channel: Public, Private

Subsegments:
1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Other Experimental Vaccines
2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines
3) By Anopheles Species: Transmission-Blocking Vaccines, Vector Control Approaches

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Which Firms Dominate the Malaria Vaccines Market by Market Share and Revenue in 2025?
Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

Which Regions Offer the Highest Growth Potential in the Malaria Vaccines Market?
North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13698

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.